Original Research
Published on 13 May 2026
Rehmannioside A alleviates neuroinflammation and cognitive impairments after traumatic brain injury by suppressing microglial activation via the MAPK/NF-κB pathway
in Neurotrauma
- 326 views
Original Research
Published on 13 May 2026
in Neurotrauma
Core Concept
Published on 13 May 2026
in Neuroscience and Psychology
Original Research
Published on 13 May 2026
in Urban Science
Mini Review
Published on 13 May 2026
in Pathological Conditions
Review
Published on 13 May 2026
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 13 May 2026
in Genitourinary Oncology
Review
Published on 13 May 2026
in Molecular Innate Immunity
Original Research
Published on 13 May 2026
in Comparative Governance
Mini Review
Published on 13 May 2026
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 13 May 2026
in Clinical Nutrition
Systematic Review
Published on 13 May 2026
in Neurological Biomarkers
Case Report
Published on 13 May 2026
in Ophthalmology
Review
Published on 13 May 2026
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 13 May 2026
in Radiation Oncology
Original Research
Published on 13 May 2026
in Virtual Reality in Medicine
Original Research
Published on 13 May 2026
in Crop and Product Physiology